Evaluation of the patient with cardiac disease undergoing noncardiac surgery

An update on the original AHA/ACC guidelines

Lee A. Fleisher

Research output: Contribution to journalArticle

Abstract

There have been many advances in the area of perioperative cardiovascular evaluation and management of the high-risk patient undergoing noncardiac surgery. Despite being based largely on expert opinion, the approach advocated in the original guidelines appears rational and cost-effective. β-blocker therapy appears to be the best strategy to reduce risk, although the optimal timing and dosage require further study.

Original languageEnglish (US)
Pages (from-to)109-120
Number of pages12
JournalInternational Anesthesiology Clinics
Volume40
Issue number2
DOIs
StatePublished - 2002

Fingerprint

Risk Management
Expert Testimony
Heart Diseases
Guidelines
Costs and Cost Analysis
Therapeutics

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Evaluation of the patient with cardiac disease undergoing noncardiac surgery : An update on the original AHA/ACC guidelines. / Fleisher, Lee A.

In: International Anesthesiology Clinics, Vol. 40, No. 2, 2002, p. 109-120.

Research output: Contribution to journalArticle

@article{a289e7f464ae43f9ab236eeacf44ece6,
title = "Evaluation of the patient with cardiac disease undergoing noncardiac surgery: An update on the original AHA/ACC guidelines",
abstract = "There have been many advances in the area of perioperative cardiovascular evaluation and management of the high-risk patient undergoing noncardiac surgery. Despite being based largely on expert opinion, the approach advocated in the original guidelines appears rational and cost-effective. β-blocker therapy appears to be the best strategy to reduce risk, although the optimal timing and dosage require further study.",
author = "Fleisher, {Lee A.}",
year = "2002",
doi = "10.1097/00004311-200204000-00010",
language = "English (US)",
volume = "40",
pages = "109--120",
journal = "International Anesthesiology Clinics",
issn = "0020-5907",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Evaluation of the patient with cardiac disease undergoing noncardiac surgery

T2 - An update on the original AHA/ACC guidelines

AU - Fleisher, Lee A.

PY - 2002

Y1 - 2002

N2 - There have been many advances in the area of perioperative cardiovascular evaluation and management of the high-risk patient undergoing noncardiac surgery. Despite being based largely on expert opinion, the approach advocated in the original guidelines appears rational and cost-effective. β-blocker therapy appears to be the best strategy to reduce risk, although the optimal timing and dosage require further study.

AB - There have been many advances in the area of perioperative cardiovascular evaluation and management of the high-risk patient undergoing noncardiac surgery. Despite being based largely on expert opinion, the approach advocated in the original guidelines appears rational and cost-effective. β-blocker therapy appears to be the best strategy to reduce risk, although the optimal timing and dosage require further study.

UR - http://www.scopus.com/inward/record.url?scp=0036213082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036213082&partnerID=8YFLogxK

U2 - 10.1097/00004311-200204000-00010

DO - 10.1097/00004311-200204000-00010

M3 - Article

VL - 40

SP - 109

EP - 120

JO - International Anesthesiology Clinics

JF - International Anesthesiology Clinics

SN - 0020-5907

IS - 2

ER -